These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 18521995)
1. Adverse drug effects: in children too. Despite treatment in line with the summary of product characteristics. Prescrire Int; 2008 Apr; 17(94):66. PubMed ID: 18521995 [No Abstract] [Full Text] [Related]
3. [Prescriptions and children]. Autret-Leca E; Bensouda-Grimaldi L; Le Guellec C; Jonville-Béra AP Arch Pediatr; 2006 Feb; 13(2):181-5. PubMed ID: 16343869 [TBL] [Abstract][Full Text] [Related]
4. [The deontological aspects of drug therapy in pediatrics]. Erenkova NV Feldsher Akush; 1991 Mar; 56(3):42-7. PubMed ID: 2044821 [No Abstract] [Full Text] [Related]
5. Association between licence status and medication errors. Conroy S Arch Dis Child; 2011 Mar; 96(3):305-6. PubMed ID: 21131639 [TBL] [Abstract][Full Text] [Related]
6. [Great risks of undertreatment. Two of three hospitalized children are not receiving approved drug treatment]. Orn P Lakartidningen; 2000 Feb; 97(7):685-7. PubMed ID: 10740374 [No Abstract] [Full Text] [Related]
7. [Dispensation of drugs to hospitalized children]. Fontan JE; Combeau D Soins Pediatr Pueric; 2000; (195):23-5. PubMed ID: 11288356 [No Abstract] [Full Text] [Related]
8. Adverse drug reactions in a department of pediatric surgery. Farrokhi S; Nahvi H; Pourpak Z; Moin M; Majdinasab P; Gholami K; Kazemnejad A J Trop Pediatr; 2006 Feb; 52(1):72-3. PubMed ID: 15980025 [No Abstract] [Full Text] [Related]
9. Medication errors in pediatric inpatients: prevalence and results of a prevention program. Otero P; Leyton A; Mariani G; Ceriani Cernadas JM; Pediatrics; 2008 Sep; 122(3):e737-43. PubMed ID: 18762510 [TBL] [Abstract][Full Text] [Related]
10. Safer prescribing for children. Marcovitch H BMJ; 2005 Sep; 331(7518):646-7. PubMed ID: 16179676 [No Abstract] [Full Text] [Related]
11. Adverse drug and medical instrument reactions in a pediatric intensive care unit. Farrokhi S; Pourpak Z; Fattahi F; Ashrafi MR; Majdinasab P; Gholami K; Moin M Pharmacoepidemiol Drug Saf; 2009 Aug; 18(8):761-2. PubMed ID: 19634150 [No Abstract] [Full Text] [Related]
12. Confusion and stroke due to an "umbrella brand" product. Prescrire Int; 2008 Aug; 17(96):161. PubMed ID: 19496250 [TBL] [Abstract][Full Text] [Related]
13. Hospitalisation for drug-related adverse effects in France. Bleeding and falls. Prescrire Int; 2009 Oct; 18(103):216. PubMed ID: 19885974 [No Abstract] [Full Text] [Related]
14. [Adverse effects of drugs in children]. Dalman C; Lönnerholm G; Wiholm BE Lakartidningen; 1988 Oct; 85(40):3280-3. PubMed ID: 3199957 [No Abstract] [Full Text] [Related]
15. [Epidemiological aspects of drug poisoning patterns. The most important iatrogenic causes. Suspicion indices]. Vallejo NE Arch Argent Pediatr; 1970 Dec; 68(10):351-3. PubMed ID: 5508172 [No Abstract] [Full Text] [Related]
16. Drug labeling and its impact on patient safety. Vredenburgh AG; Zackowitz IB Work; 2009; 33(2):169-74. PubMed ID: 19713626 [TBL] [Abstract][Full Text] [Related]